News

Latest news

7th November 2022

Dr Michihiko Wada joins Newton Biocapital as an Advisor, Clinical and Medical Sciences

Read more
7th November 2022

ニュートン バイオキャピタル、和田 道彦博士とフィリップ デバッカー博士の参画で、 チーム体制をさらに強化

Read more
25th October 2022

Sequana Medical announces positive top-line results from the North American pivotal alfapump® study (POSEIDON)

Read more
24th October 2022

Data from Roll-In Cohort of North American pivotal alfapump® study (POSEIDON) selected for poster presentation at AASLD The Liver Meeting®

Read more
20th October 2022

Acticor Biotech strenghtens its financial structure

Read more
3rd October 2022

論文掲載のお知らせ：世界初となる”U-to-C”の遺伝子編集をヒト細胞で実現しました

Read more
30th September 2022

EditForce Realizes RNA-editing Technology of “U-to-C” in Human Cells

Read more
29th September 2022

Philippe De Backer joins Newton Biocapital as a Senior Partner

Read more
15th September 2022

Sequana Medical announces H1 2022 results and provides business update

Read more